Navigation Links
Epilepsy Drugs Market in Europe - Market Analysis 2015-2019 - Reportlinker Review
Date:10/12/2015

NEW YORK, Oct. 12, 2015 /PRNewswire/ -- About epilepsy

Epilepsy refers to a spectrum of brain disorders manifested by benign to severe, disabling, and life-threatening symptoms. It is caused by factors ranging from brain malformations and tumors to meningitis, high-risk pregnancies, and trauma during birth. When the underlying cause of the disease is unidentified, as is witnessed in the majority of cases, it is known as idiopathic epilepsy. An imbalance between the inhibitory and excitatory signals of the brain, leading to a sudden onset of excitation, results in seizures.

Technavio's analysts forecast the epilepsy drugs market in Europe to grow at a CAGR of 3.22% over the period 2014-2019.

Covered in this report

The report includes the present scenario and the growth prospects of the epilepsy drugs market in Europe for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of epilepsy.

Technavio's report, Epilepsy Drugs Market in Europe 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It covers the market size and forecast as well as market segmentation and pipeline landscape. The report includes a discussion of the key vendors operating in this market.

Key vendors

• Eisai

• GlaxoSmithKline

• Pfizer

• UCB

Other prominent vendors

• AbbVie• Janssen Pharmaceuticals• Lundbeck• Meda• Novartis• Roche• Shire• Sunovion Pharmaceuticals• Supernus Pharmaceuticals• Upsher-Smith• Valeant Pharmaceuticals

Market driver

• Unmet medical needs

• For a full, detailed list, view our report

Market challenge

• Patent expiry• For a full, detailed list, view our report

Market trend

• Reformulation of marketed drugs

• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2019 and what will the growth rate be?• What are the key market trends?• What is driving this market?• What are the challenges to market growth?• Who are the key vendors in this market space?• What are the market opportunities and threats faced by the key vendors?• What are the strengths and weaknesses of the key vendors?

Read the full report: http://www.reportlinker.com/p03312084-summary/view-report.html

About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker reviews, finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

 


'/>"/>
SOURCE Reportlinker
Copyright©2015 PR Newswire.
All rights reserved


Related medicine technology :

1. PhRMA and Epilepsy Foundation Report More Than 400 Medicines in Development to Treat Neurological Disorders
2. Memorial Hermann Successfully Completes Systems First NeuroPace RNS System Procedure for Epilepsy Patient
3. Epilepsy Drug May Preserve Eyesight for People with MS
4. Medical Marijuana Liquid Extract May Bring Hope for Children with Severe Epilepsy
5. Eisai Presents New Data on Perampanel and Rufinamide at the 68th Annual American Epilepsy Society Meeting
6. UCB, Georgia Institute of Technology Partner to Harness the Power of Predictive Analytics in Epilepsy Care
7. UCB reinforces its leadership in epilepsy at the 2014 Annual Meeting of the American Epilepsy Society (AES)
8. Northwest Epilepsy Conferences to Highlight Marijuana Treatments
9. PuraMed BioScience Nears Completion of a Hemp-Derived-Cannabinoid-Based Non-Prescription Medication for Treatment of Epilepsy Symptoms
10. Landmark National Survey Seeks To Shed Light On Impact Of Rare Seizure Pattern In Epilepsy
11. Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2019)... ... August 16, 2019 , ... The ... Bend Emergency Physicians (SBEP) of Indiana as a member group. , SBEP is ... South Bend. , SBEP sought out the AAEM-PG for administrative and practice ...
(Date:8/16/2019)... NEW YORK (PRWEB) , ... August 16, 2019 ... ... first-in-class brain aminopeptidase inhibitor (BAPAI) that could potentially treat treatment-resistant hypertension by acting ... that there are around 150 million people worldwide that are affected by treatment-resistant ...
(Date:8/16/2019)... ... August 16, 2019 , ... Today, Point-of-Care Partners announced Government ... has joined the company as a Government Affairs and Health IT Strategist. In ... standards organizations to advance use of health IT for comprehensive medication management. , ...
Breaking Medicine Technology:
(Date:8/14/2019)... N.H. (PRWEB) , ... August 13, 2019 , ... New ... the heart-healthy antioxidant resveratrol, today announced an expansion of its line of CBD-infused coffees ... 300 mg of CBD in a 12-oz bag. , “We are excited to ...
(Date:8/14/2019)... PLEASANT HILL, Calif. (PRWEB) , ... August 13, 2019 , ... ... has welcomed Maria P. Falaschi, vice president of operations and information technology, and Elie ... growing executive team as part of New U Life’s commitment to expanding its corporate ...
(Date:8/12/2019)... (PRWEB) , ... August 12, 2019 , ... Eco ... Boulevard #315 in Pembroke Pines, Florida 33027. For over 25 years, Eco Pump Services ... and septic tank pumping services . Eco Pump’s steady five-star ratings and ...
(Date:8/12/2019)... ... August 12, 2019 , ... ... the $56,595,000 Series 2019A&B Bonds for Lesley University, which is currently rated A-/Stable ... 2019 Bonds will be used primarily to refund the outstanding debt on the ...
(Date:8/9/2019)... ... , ... The Los Angeles employment law lawyers at Blumenthal Nordrehaug Bhowmik ... Food Markets, Inc., failed to provide their California employees with meal and rest periods ... lawsuit, Case No. 19STCV26728, is currently pending in the Los Angeles County Superior Court ...
Breaking Medicine News(10 mins):